O. Fromigué

P. Barbry, F. Lecanda, O. Fromigué, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors

P. Opolon, O. Bawa, O. Fromigué, 2014, Oncogene.

Lentiviral-mediated integrin α5 expression in human adult mesenchymal stromal cells promotes bone repair in mouse cranial and long-bone defects.

R. Müller, O. Fromigué, P. Marie, 2012, Human gene therapy.

Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts

O. Fromigué, J. Body, 2002, Journal of endocrinological investigation.

Synergistic Anti-Tumor Effect of Simvastatin Combined to Chemotherapy in Osteosarcoma

O. Fromigué, Adèle Mangelinck, N. Gaspar, 2021, Cancers.

Priming integrin α5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis

J. Ringe, O. Fromigué, P. Marie, 2009, Proceedings of the National Academy of Sciences.

Plasticity and regulation of human bone marrow stromal osteoprogenitor cells: potential implication in the treatment of age-related bone loss.

O. Fromigué, P. Marie, S. Ahdjoudj, 2004, Histology and histopathology.

Role of Protein Kinase C and Interleukin-1

O. Fromigué, P. Marie, P. Delannoy, 2001 .

Recent advances in understanding osteosarcoma and emerging therapies

A. Marchais, O. Fromigué, P. Berlanga, 2020, Faculty reviews.

Bisphosphonates Induce Breast Cancer Cell Death In Vitro

O. Fromigué, J. Body, L. Lagneaux, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Priming integrin alpha5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis

J. Ringe, O. Fromigué, P. Marie, 2009 .

Transforming growth factor-beta inhibits CCAAT/enhancer-binding protein expression and PPARgamma activity in unloaded bone marrow stromal cells.

O. Fromigué, X. Holy, P. Marie, 2005, Experimental cell research.

Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.

O. Fromigué, P. Marie, C. Bazille, 2007, Cancer research.

Syndecan-2 overexpression induces osteosarcoma cell apoptosis: Implication of syndecan-2 cytoplasmic domain and JNK signaling.

O. Fromigué, P. Marie, D. Modrowski, 2005, Bone.

Essential Role of Nuclear Factor of Activated T Cells (NFAT)-mediated Wnt Signaling in Osteoblast Differentiation Induced by Strontium Ranelate*

O. Fromigué, P. Marie, E. Haÿ, 2010, The Journal of Biological Chemistry.

Calcium sensing receptor‐dependent and receptor‐independent activation of osteoblast replication and survival by strontium ranelate

O. Fromigué, P. Marie, E. Haÿ, 2009 .

Autocrine fibroblast growth factor 18 mediates dexamethasone‐induced osteogenic differentiation of murine mesenchymal stem cells

Franz Jakob, U. Nuber, O. Fromigué, 2010, Journal of cellular physiology.

Bone Morphogenetic Protein-2 Promotes Osteoblast Apoptosis through a Smad-independent, Protein Kinase C-dependent Signaling Pathway*

J. Lemonnier, O. Fromigué, P. Marie, 2001, The Journal of Biological Chemistry.

Bone morphogenetic protein‐2 and transforming growth factor‐β2 interact to modulate human bone marrow stromal cell proliferation and differentiation

O. Fromigué, P. Marie, A. Lomri, 1998 .

Characterization of distinct mesenchymal-like cell populations from human skeletal muscle in situ and in vitro.

J. Larghero, M. Fiszman, O. Fromigué, 2010, Experimental cell research.

Tribbles Pseudokinase 3 Regulation and Contribution to Cancer

F. André, O. Fromigué, B. Stefanovska, 2021, Cancers.

Whole exome sequencing of rare aggressive breast cancer histologies

Guangliang Yin, C. Lefebvre, M. Mathieu, 2016, Breast Cancer Research and Treatment.

Transforming growth factor-β inhibits CCAAT/enhancer-binding protein expression and PPARγ activity in unloaded bone marrow stromal cells

O. Fromigué, X. Holy, P. Marie, 2005 .

CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process

A. Patiño-García, F. Lecanda, O. Fromigué, 2019, BMC Cancer.

Rapalog-Mediated Repression of Tribbles Pseudokinase 3 Regulates Pre-mRNA Splicing

F. André, V. Ogryzko, O. Trédan, 2020, Cancer Research.

Genomic Insertion of the SV-40 Large T Oncogene in Normal Adult Human Trabecular Osteoblastic Cells Induces Cell Growth Without Loss of the Differentiated Phenotype

O. Fromigué, P. Marie, A. Lomri, 1999, Calcified Tissue International.

Gene expression profiling of normal human pulmonary fibroblasts following coculture with non-small-cell lung cancer cells reveals alterations related to matrix degradation, angiogenesis, cell growth and survival

G. Pagès, P. Barbry, P. Auberger, 2003, Oncogene.

Targeting the E3 ubiquitin casitas B‐lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis

A. Patiño-García, F. Lecanda, O. Fromigué, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Deregulation of osteoblast differentiation in primary bone cancers

O. Fromigué, P. Marie, D. Modrowski, 2015 .

RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation

P. Auberger, O. Fromigué, A. Jacquel, 2006, Cell Death and Differentiation.

Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation

Jochen Ringe, Thomas Häupl, J. Ringe, 2010, BMC Cell Biology.

Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts.

O. Fromigué, P. Marie, S. Mée, 2005, Experimental cell research.

Statin-Induced Inhibition of 3-Hydroxy-3-Methyl Glutaryl Coenzyme A Reductase Sensitizes Human Osteosarcoma Cells to Anticancer Drugs

O. Fromigué, P. Marie, Z. Hamidouche, 2008, Journal of Pharmacology and Experimental Therapeutics.

Bone Morphogenetic Protein Receptor IB Signaling Mediates Apoptosis Independently of Differentiation in Osteoblastic Cells*

J. Lemonnier, O. Fromigué, P. Marie, 2004, Journal of Biological Chemistry.

Immune infiltrate and tumor microenvironment transcriptional programs stratify pediatric osteosarcoma into prognostic groups at diagnosis.

D. Drubay, B. Job, B. Geoerger, 2022, Cancer research.

Topographically induced self-deformation of the nuclei of cells: dependence on cell type and proposed mechanisms

Karine Anselme, Vasif Hasirci, Günter Reiter, 2010, Journal of materials science. Materials in medicine.

Blockade of the RhoA-JNK-c-Jun-MMP2 Cascade by Atorvastatin Reduces Osteosarcoma Cell Invasion*

O. Fromigué, P. Marie, Z. Hamidouche, 2008, Journal of Biological Chemistry.

Active stromelysin‐3 (MMP‐11) increases MCF‐7 survival in three‐dimensional Matrigel culture via activation of p42/p44 MAP‐kinase

M. Shipp, P. Auberger, O. Fromigué, 2003, International journal of cancer.

Breast Cancer Cells Release Factors That Induce Apoptosis in Human Bone Marrow Stromal Cells *

O. Fromigué, P. Marie, J. Body, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Tumor Cell-mediated Induction of the Stromal Factor Stromelysin-3 Requires Heterotypic Cell Contact-dependent Activation of Specific Protein Kinase C Isoforms*

M. Shipp, P. Auberger, O. Fromigué, 2005, Journal of Biological Chemistry.

Growth factors and bone formation in osteoporosis: roles for fibroblast growth factor and transforming growth factor beta.

O. Fromigué, P. Marie, D. Modrowski, 2004, Current pharmaceutical design.

In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG Mice

B. Job, B. Geoerger, A. Marchais, 2019, Cancers.

Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance

I. Girault, A. Patiño-García, F. Lecanda, 2013, Cell Death and Disease.

Dual involvement of protein kinase C δ in apoptosis induced by syndecan‐2 in osteoblasts

O. Fromigué, P. Marie, E. Haÿ, 2006 .

FHL2 Silencing Reduces Wnt Signaling and Osteosarcoma Tumorigenesis In Vitro and In Vivo

A. Patiño-García, F. Lecanda, R. Schüle, 2013, PloS one.

MT2A is an early predictive biomarker of response to chemotherapy and a potential therapeutic target in osteosarcoma

O. Bawa, O. Fromigué, Adèle Mangelinck, 2019, Scientific Reports.

Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation.

O. Fromigué, P. Marie, A. Lomri, 1998, Journal of cellular biochemistry.

Collagen supramolecular and suprafibrillar organizations on osteoblasts long-term behavior: benefits for bone healing materials.

O. Fromigué, P. Marie, M. Giraud‐Guille, 2010, Journal of biomedical materials research. Part A.

Apoptosis in membranous bone formation: role of fibroblast growth factor and bone morphogenetic protein signaling.

O. Fromigué, P. Marie, D. Modrowski, 2005, Critical reviews in eukaryotic gene expression.